Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-065100
Filing Date
2025-05-07
Accepted
2025-05-07 09:00:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16603
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 386039
  Complete submission text file 0000950170-25-065100.txt   544764
Mailing Address FRANCES HOUSE, PO BOX 273 SIR WILLIAM PLACE ST PETER PORT, GUERNSEY X0 GY1 3 RD
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A

Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Subject) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90550 | Film No.: 25919502
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)